Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-04-26 00:00:00 ET · period of report 2024-04-24 · accession 0001510281-24-000255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-04-26 | 2024-04-24+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.01 | +118.1K | 2.81M | +4% | +$1.54M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-25 | P | A | 97,574 | $12.99 | 2,905,298 | I - | — | — | |
| 2 | Common | Common Stock | 2024-04-24 | P | A | 20,529 | $13.12 | 2,807,724 | I - | — | — |